Quick Read Altria (MO) gained 105% on price alone over a decade but trails the S&P 500’s 224% return, while Philip Morris (PM) rose 179% on price; dividend reinvestment over 10 years significantly closed the gap for both, with Altria’s quarterly dividend nearly doubling from $0.565 to $1.06 and PM’s rising from $1.02 to $1.47. PM trades at 20x forward P/E with analyst upside to $194.84 while Altria offers a 6.5% yield at 12x forward P/E amid domestic cigarette declines. Both companies offset structural ...

Had You Invested $1,000 in Altria or Philip Morris 10 Years Ago, Here's What You'd Have Now - 24/7 Wall St. S&P 5006,599.20 -0.34% Nasdaq 10024,287.60 -0.57% Russell 20002,469.48 -0.12% FTSE 10010,071.20 -1.53% Nikkei 22552,600.50 -1.85% Stock Market Live March 19, 2026: S&P 500 (SPY) Slips on Gushing Oil Prices Investing Had You Invested $1,000 in Altria or Philip Morris 10 Years Ago, Here's What You'd Have Now By Trey ThoelckePublished Mar 19, 10:30AM EDT Quick Read Dow Jones45,934.00 -0.43% Both companie ...

Core Insights - Philip Morris International (PM) reported full-year 2025 revenue of $40.6 billion, with smoke-free products contributing approximately $17 billion, while British American Tobacco (BTI) reported Q4 2025 EPS of $2.55, exceeding estimates, and raised its 2026 quarterly dividend to $0.835 from $0.749 [1] - PM's IQOS maintained a 76% global market share in heated tobacco, and ZYN saw a 37% growth in shipments in the U.S. with 794 million cans shipped [1] - PM trades at a trailing P/E of 23x, reflecting consistent earnings and growth in smoke-free products, while BTI trades at 13x, offering a higher yield but with a more volatile earnings history [1] Financial Performance - PM's adjusted operating income margin expanded to 40.4%, with management guiding for adjusted diluted EPS of $8.38 to $8.53 in 2026, indicating an expected growth of 11% to 13% [1] - BTI's Q4 2025 EPS of $2.55 beat the estimate of $2.51, but its smoke-free brands are growing at a slower pace compared to PM [1] - PM's revenue growth is driven by its smoke-free segment, while BTI's earnings history shows inconsistencies, including a -$0.66 EPS in Q4 2024 and a significant miss in Q2 2025 [1] Investment Considerations - PM is positioned as a growth stock with a focus on smoke-free transformation, appealing to investors seeking capital appreciation alongside dividend growth [1] - BTI offers a higher dividend yield of 5.64% compared to PM's 3.26%, making it attractive for income-focused investors despite its lower growth narrative [1] - The valuation gap between PM and BTI reflects differing investment profiles, with PM commanding a premium due to its consistent earnings performance and growth potential [1]

Westin: This is a story about the many faces of a single vice. For more than a century, tobacco has been one of the most regulated industries in the global economy. And with every new regulation, it's come back in a different form.Now, tobacco firms are adapting again sidelining cigarettes in favor of smoke-free products. They call it "harm reduction." And are finding some business success. But critics say the long-term health effects are still unknown.Our colleague, Michael McKee, takes us to Switzerland. ...

Core Insights - The tobacco industry is transitioning from traditional cigarettes to smoke-free products, emphasizing "harm reduction" as a new business strategy [1][2] - Smoke-free products are now consumed by over 100 million people globally, with projections indicating significant revenue growth by 2030 [2] - Despite the industry's shift, critics express concerns about the long-term health effects of these new products [1][28] Industry Transition - Philip Morris International (PMI) is leading the charge in this transition, with a market capitalization of nearly $300 billion, larger than major companies like Goldman Sachs and Disney [13] - Approximately 40% of PMI's revenues now come from smoke-free products, including Iqos and Zyn, which are designed to be less harmful alternatives to traditional cigarettes [13][16] - Iqos, a heat-not-burn device, has seen a high adoption rate, with 70% of users reportedly stopping smoking entirely after switching [15] Product Overview - Zyn is a tobacco-free nicotine pouch that has gained popularity for its discreet use and variety of flavors, while Iqos replicates the smoking experience without combustion [14][19] - Global shipments of Zyn are expected to double from 421 million in 2023 to an estimated 1 billion by 2026, reflecting a growing demand for nicotine pouches [20] - The nicotine pouch market has experienced over 35% growth in both the U.S. and Europe last year, indicating a strong consumer shift towards these products [20] Health Concerns - Critics argue that while smoke-free products may be less harmful than cigarettes, they still pose health risks due to nicotine addiction [22][27] - Research on the long-term health outcomes of nicotine pouches is still lacking, necessitating further studies to understand their impact [28] - Users have reported health issues related to Zyn, highlighting the potential for addiction and withdrawal symptoms associated with nicotine use [25][29] Market Dynamics - The nicotine market continues to expand as consumers seek alternatives to traditional cigarettes, driven by an innate craving for nicotine [30] - The industry's bet is that nicotine cravings will persist even as cigarette sales decline, suggesting a long-term market for smoke-free products [31]

Investment Rating - The industry investment rating is "Buy" [1] Core Insights - The tobacco sector demonstrates both offensive and defensive attributes, with stable earnings growth and high dividends driving stock price increases. The sector benefits from a declining interest rate environment, making high-dividend stocks more attractive [7][22][30] - Tobacco stocks have shown significant excess returns since the Federal Reserve initiated a rate-cutting cycle in September 2024, with British American Tobacco and Philip Morris International achieving cumulative returns of 110% and 96% respectively from January 2024 to February 2026, outperforming the S&P 500 [20][22] - Philip Morris International's growth is driven by regional and product diversification, with its smoke-free products accounting for 41.5% of total net revenue by 2025, effectively offsetting declines in traditional cigarette sales [5][25][26] Summary by Sections Tobacco Sector Analysis - The tobacco sector's defensive characteristics stem from its inelastic demand and strong cash flow, with dividend yields typically ranging from 5% to 7%. This stability attracts investors, especially during periods of declining bond yields [22][30] - Philip Morris International's revenue growth is attributed to its expansion in Asia and Latin America, as well as the introduction of reduced-risk products (RRP) since 2016, which have significantly contributed to its earnings per share (EPS) growth [5][25][26] Domestic Market Focus - The 2026 National Tobacco Work Conference emphasizes the development of a modern tobacco industry system and the promotion of high-quality international business growth. China Tobacco Hong Kong holds exclusive rights in the duty-free cigarette export market, enhancing its value proposition [6][29][30] - The new regulations are expected to optimize the supply chain for cigarette exports to the domestic duty-free market, potentially increasing profit margins for China Tobacco Hong Kong [30][32] Investment Recommendations - The report suggests actively monitoring companies like China Tobacco Hong Kong and Smoore International, which exhibit both growth potential and defensive characteristics in the current market environment [7][30]

Core Insights - Altria Group, Inc. is focusing on its smoke-free strategy, particularly through its oral nicotine portfolio, which has shown significant growth, with nicotine pouches driving a 14% volume increase over the past six months [1][8] Oral Nicotine Market Performance - By Q4 2025, oral nicotine pouches represented nearly 57% of the total oral category, gaining 10.4 share points year over year, indicating a rapid consumer shift within oral tobacco [2] - Altria's flagship pouch brand, on!, demonstrated resilience amid competitive pricing pressures, with a 3% price increase while the broader category saw a 12% decline in pricing [3] - For the full year 2025, on! shipment volumes increased by 10.9% to over 177 million cans, maintaining an 8.2% retail share of the total oral tobacco category, up 0.1 share point from the previous year [3][8] Future Growth Potential - The momentum for Altria's oral nicotine products is expected to strengthen further in 2026 with the national launch of on! PLUS, a premium pouch that has received FDA marketing authorization for three varieties, targeting high-velocity segments [4] Competitive Landscape - Philip Morris International Inc. reported net revenues of $16.9 billion from its smoke-free segment in 2025, contributing 41.5% to total revenues, driven by the global expansion of IQOS and increased U.S. ZYN shipments [5] - Turning Point Brands, Inc. experienced a remarkable 627.6% year-over-year increase in its Modern Oral segment, with white nicotine pouches accounting for 30.8% of total business by the end of Q3 2025 [6] Valuation and Estimates - Altria's shares have increased by 10.9% in the past month, outperforming the industry growth of 5% [7] - The company trades at a forward price-to-earnings ratio of 12.32X, lower than the industry average of 16.2X [9] - The Zacks Consensus Estimate for Altria's earnings per share for 2026 is $5.57, with a slight decrease of 1 cent, while the estimate for 2027 has increased by 5 cents to $5.76 [10]

Core Insights - Altria Group, Inc. and Philip Morris International Inc. are leading companies in the global tobacco industry, focusing on cigarette and nicotine product sales amid changing consumer preferences [1][2] - Altria has a market capitalization of approximately $116.6 billion, while Philip Morris has a larger market value of around $291.9 billion, reflecting its international presence and leadership in next-generation products [1][2] Altria Group, Inc. Overview - Altria's investment appeal is supported by resilient cash-flow generation and consistent shareholder returns, with a 4.4% adjusted EPS growth in 2025 and approximately $8 billion returned to shareholders through dividends and share repurchases [3][4] - The smokeable products segment generated over $11 billion in adjusted operating income in 2025, with margins expanding to 63.4% due to strong pricing execution [4] - Altria is advancing its smoke-free portfolio, particularly in modern oral nicotine, with a 10.9% shipment volume growth for the on! brand in 2025 [5] - Domestic cigarette volumes declined approximately 9.5% in 2025, indicating ongoing pressure in the combustible category [6] Philip Morris International Inc. Overview - Philip Morris demonstrated a strong growth profile in 2025 with a 14.8% adjusted EPS growth, net revenues exceeding $40 billion, and organic operating income growth of 10.6% [7][8] - Smoke-free products accounted for 41.5% of total net revenues and nearly 43% of gross profit in 2025, with IQOS heated tobacco units and ZYN nicotine pouches showing significant growth [9][10] - Despite a 1.5% decline in combustible cigarette shipments, pricing actions helped lift combustible net revenues by 2.5% [10] - Management projects 2026 adjusted EPS growth of 11.1% to 13.1%, indicating confidence in the company's operating momentum [11] Comparative Analysis - Altria's shares increased by 26.1% over the past year, outperforming Philip Morris's 21.7% gain, although both lagged behind the industry growth of 33.8% [12] - Altria trades at a forward P/E ratio of 12.4, while Philip Morris trades at a forward P/E of 21.82, indicating differing valuations [16] - Philip Morris is viewed as the stronger growth story due to its accelerated shift toward smoke-free products and global scale, while Altria is seen as a stable income choice reliant on its U.S. combustible franchise [17]

Group 1 - Philip Morris International Inc. (PM) is recognized as one of the 13 Best Long-Term Dividend Stocks to invest in currently [1] - Argus has raised its price target for PM from $190 to $210, maintaining a Buy rating, citing the expected growth from ZYN nicotine pouches [2] - During the Q4 2025 earnings call, PM reported a 12.8% increase in smoke-free product volumes and an 18.7% rise in organic smoke-free gross profit, indicating strong growth and profitability in this segment [3] Group 2 - CEO Jacek Olczak highlighted that IQOS remains the primary growth driver for PM, with shipment volumes and adjusted in-market sales both increasing by approximately 11% [4] - PM has expanded its smoke-free product presence to 106 markets, showcasing its global rollout strategy [4] - The company reported that shipment volumes for ZYN outside the Nordic region and VEEV in international markets more than doubled, with ZYN gaining significant market share [4][5]

Core Insights - The article highlights the strength of consumer staples stocks, particularly through the iShares Global Consumer Staples ETF (KXI), which offers a defensive investment strategy amid macroeconomic uncertainty and recessionary consumer sentiment [1][2] Group 1: Company Performance - Philip Morris International generated $17 billion in smoke-free revenue in 2025, accounting for 41.5% of total revenue, with a 14.8% increase in adjusted EPS to $7.54 [1] - Walmart's Q4 FY2026 revenue reached $190.66 billion, up 5.6% year-over-year, with global eCommerce growing 24% and a new $30 billion share buyback authorized [1] - Coca-Cola increased its dividend for the 63rd consecutive year, paying $8.78 billion in dividends during 2025, while Q4 2025 revenue was $11.82 billion, missing estimates [1] Group 2: Dividend Growth and Stability - Procter & Gamble has increased its dividend for 68 consecutive years, with a current quarterly payout of $1.0568 per share, despite a revenue miss in Q2 FY2026 [1] - Costco Wholesale reported a quarterly EPS of $4.50, beating estimates, with net sales up 8.2% and a membership income growth of 14% [1] - The KXI ETF has a 2.27% dividend yield and has returned 13.57% year-to-date, showcasing the income generation potential of its holdings [1][2] Group 3: Market Context - The University of Michigan Consumer Sentiment index is at 56.4, indicating recessionary conditions, while inflation is running at 2.16% year-over-year, supporting the defensive case for consumer staples [2] - The KXI ETF has shown resilience, outperforming the S&P 500 with less volatility, making it an attractive option for investors seeking stability [2]